503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-5.05%
Negative net income growth while BB stands at 105.96%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
4.36%
D&A growth well above BB's 0.38%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
61.43%
Some yoy growth while BB is negative at -196.15%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-0.66%
Negative yoy SBC while BB is 23.53%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
88.04%
Less working capital growth vs. BB's 377.27%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
148.82%
AR growth of 148.82% while BB is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-1363.64%
Negative yoy inventory while BB is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-109.78%
Negative yoy AP while BB is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
7.23%
Growth of 7.23% while BB is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-11.34%
Both negative yoy, with BB at -28.57%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
102.22%
Operating cash flow growth at 75-90% of BB's 125.94%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
No Data
No Data available this quarter, please select a different quarter.
65.27%
Some acquisitions while BB is negative at -7.91%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-80.27%
Both yoy lines negative, with BB at -132.52%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
20.63%
Below 50% of BB's 83.77%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
238.17%
Growth well above BB's 7.91%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-195.41%
Both yoy lines negative, with BB at -31.12%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while BB is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
40.00%
Issuance growth of 40.00% while BB is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
38.00%
Buyback growth of 38.00% while BB is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.